Please enter verification code
Role of Comprehensive Diabetes Care in Known Diabetes Patients from Vidarbha Region
International Journal of Diabetes and Endocrinology
Volume 5, Issue 3, September 2020, Pages: 41-46
Received: Jul. 13, 2020; Accepted: Jul. 27, 2020; Published: Sep. 3, 2020
Views 174      Downloads 54
Rohit Sane, Madhavbaug Cardiac Hospitals and Clinics, Thane, India
Rahul Mandole, Department of Research & Development, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Gurudatta Anand Amin, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Pravin Ghadigaokar, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Sneha Paranjape, Madhavbaug Cardiac Clinic and Hospital, Mumbai, India
Komal Vasnik, Madhavbaug Cardiac Clinic and Hospital, Vidarbha, India
Sumera Sabir, Madhavbaug Cardiac Clinic and Hospital, Dhantoli, Nagpur, India
Rupali Kaware, Madhavbaug Cardiac Clinic and Hospital, Rajpath, Amravati, India
Rakesh Kukade, Madhavbaug Cardiac Clinic and Hospital, Mhalgi Nagar, Nagpur, India
Article Tools
Follow on us
Introduction: Number of patients with Diabetes Mellitus (DM) have been doubled in past few decades. India is particularly facing impending massive rise in number of diabetic cases, and therefore India is termed as Diabetes capital of the world by most of the clinicians. Worryingly, prevalence in Vidarbha region in India is rising and its figure as per published literature is >5%. Comprehensive diabetes care (CDC) is form of Ayurvedic therapy which combines panchkarma techniques and herbal drugs. Aims and objectives: The present study was initiated to evaluate the effectiveness of CDC in patients of DM in terms of glycosylated haemoglobin (HbA1c), body mass index (BMI), oral glucose tolerance test (OGTT), body weight, abdominal girth, etc. in Vidarbha region of India. Materials and methods: The present observational study was conducted across various Madhavbaug clinics in Vidarbha region of India. Data of the patients who were diagnosed with DM i.e. HbA1c>6.5% and received CDC therapy of 6 settings over 12 weeks was analysed. Results: In the present study, out of 293 type 2 diabetic patients, 179 were males (61%), while 114 were females (39%), thus male: female ratio was 1.57:1. At the end of 12 weeks of CDC therapy, number of patients with controlled DM (154) was significantly increased as compared to baseline (0), while the HbA1c also reduced from 6.89 at week 12 as compared to 8.45 at baseline, which was statistically significant. Other parameters like BMI, abdominal girth, etc. were significantly improved after 12 weeks of CDC therapy. Conclusion: Given the findings of present study, CDC therapy can be used as efficacious alternative form of therapy in the management of DM.
Diabetes Mellitus, Comprehensive Diabetes Care, Ayurveda, Panchkarma
To cite this article
Rohit Sane, Rahul Mandole, Gurudatta Anand Amin, Pravin Ghadigaokar, Sneha Paranjape, Komal Vasnik, Sumera Sabir, Rupali Kaware, Rakesh Kukade, Role of Comprehensive Diabetes Care in Known Diabetes Patients from Vidarbha Region, International Journal of Diabetes and Endocrinology. Vol. 5, No. 3, 2020, pp. 41-46. doi: 10.11648/j.ijde.20200503.12
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov; 157: 107843.
Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator 2009; XXII (1, 2): 1- 18.
American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010 Jan; 33 (Suppl 1): S62–S69.
Forbes JM, Cooper ME. Mechanisms of Diabetic Complications. Physiol Rev. 2013; 93: 137–188.
Madhu S, Srivastava S. Diabetes Mellitus: Diagnosis and Management Guidelines. JIMSA 2015; 28 (1): 47-50.
Piero N, Murugi N, Mwiti K, et al. Pharmacological Management of Diabetes Mellitus. Asian Journal of Biochemical and Pharmaceutical Research 2012; 2 (2): 375-380.
Alawdi S. Effect of Medication Adherence to Oral Hypoglycemic Drugs on Glycemic Control in Type 2 Diabetic Patients: a Cross Sectional Study. Saudi J Med Pharm Sci. 2019; 5 (6): 543-547.
Dwivedi C, Daspaul S. Antidiabetic Herbal Drugs and Polyherbal Formulation Used For Diabetes: A Review. The Journal of Phytopharmacology 2013; 2 (3): 44-51.
Srikanth N, Haripriya N, Singh R, et al. Diabetes mellitus (madhumeha) and ayurvedic management: an evidence based approach. World Journal of Pharmacy and Pharmaceutical Sciences 2015; 4 (8): 881-892.
Sane R, Ghadigaonkar P, Chaure R, Jain S, Wahane S, Nadapude A, et al. Efficacy of Comprehensive Diabetes Care (CDC) Management Program in Elderly Male Patients of Type II Diabetes Mellitus: A Retrospective Study. International Journal of Diabetes and Endocrinology 2018; 3 (2), 2018: 29-34.
Modi D, Rathod G, Delwadia K, et al. Study of significance of glycosylated hemoglobin in diabetic patient. IAIM, 2016; 3 (4): 1-10.
Buse J, Bigger J, Byington R, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007; 99 (12A): 21i-33i.
Gerstein H, Riddle M, Kendall D, et al. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007; 99 (12A): 34i-43i.
Gerstein H, Miller M, Byington R, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358 (24): 2545-59.
Al-Goblan A, Al-Alfi M, Khan M. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014; 7: 587–591.
Alzohairy M. Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evid Based Complement Alternat Med. 2016; 2016: 7382506.
Taylor R. Calorie restriction and reversal of type 2 diabetes. Expert Rev Endocrinol Metab. 2016 Nov; 11 (6): 521-528.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186